Day One Biopharmaceuticals · 1 week ago
Associate Director, Thought Leader Liaison
Day One Biopharmaceuticals is focused on advancing first- or best-in-class medicines for childhood and adult diseases. The Associate Director, Thought Leader Liaison is responsible for building relationships with key opinion leaders and executing the thought leader and regional marketing strategy, requiring deep clinical knowledge and commercial acumen.
BiopharmaBiotechnologyHealth CarePharmaceutical
Responsibilities
Identify, cultivate, and maintain professional relationships with national, regional, and emerging KOLs and other key stakeholders
Assess where customers are in their engagement and advocacy journey and deploy tactics to deepen engagement and advocacy
Identify and secure KOLs for key projects and initiatives
Conduct 1:1 and small-group engagements to strengthen advocacy and enhance understanding of the disease area and product data
Collaborate with the thought leader strategy lead and other cross-functional teams to develop/update KOL strategy and engagement plans
Gather and share actionable insights from KOL interactions to inform brand strategy and execution
Identify and monitor emerging trends, sentiment shifts, and competitive activity, ensuring timely communication to the broader commercial organization
Stay current on data readouts, congress presentations, and scientific developments to support informed KOL discussions
Translate national brand strategy into actionable regional marketing plans including key account strategy and plans that address regional opportunities and barriers
Lead regional cross-functional initiatives in collaboration with Sales, Medical Affairs, and other cross functional partners in a compliant manner
Partner with sales and medical leadership teams and field teams to ensure strategic alignment across KOLs, accounts and customer segments
Act as a collaborative, field-based marketing partner to Sales and Medical, supporting account access and relationship development, especially in hard-to-reach or strategically important accountsIdentify and facilitate educational and partnership opportunities with professional societies and centers of excellence
Lead compliant execution of regional speaker programs and P2P educational events
Provide ongoing coaching and feedback to ensure message consistency and speaker excellence
Partner with field teams to identify, vet, and contract qualified speakers based on regional needs
Collaborate with regional business directors to plan and execute programs aligned with educational priorities
Lead thought leader engagement planning and execution at key national and regional congresses
Coordinate on-site KOL meetings, non-CME educational events, and customer receptions in collaboration with cross-functional teams
Partner across Sales, Medical Affairs, and cross-functional teams to ensure coordinated and compliant external engagement
Qualification
Required
Bachelor's degree required
8+ years of biotech or pharmaceutical industry experience, including at least 5 years in a customer-facing or marketing role (e.g., Sales, MSL, KOL Management, Field Marketing/TLL)
Strong understanding of the U.S. healthcare landscape and experience engaging with thought leaders in specialty therapeutic areas
Proven ability to build and sustain trusted professional relationships
Strong collaboration and communication skills with demonstrated cross-functional leadership
Experience developing and executing thought leader engagement or regional marketing strategies
Strong clinical and scientific acumen
Excellent presentation, communication, and storytelling abilities
Deep understanding of compliance and regulatory frameworks governing HCP engagement
Entrepreneurial mindset with the ability to thrive in a fast-paced, mission-driven environment
Preferred
advanced degree (MBA, MS, PharmD, or equivalent)
Company
Day One Biopharmaceuticals
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Funding
Current Stage
Public CompanyTotal Funding
$687.5MKey Investors
RA Capital Management
2024-07-30Post Ipo Equity· $175M
2023-06-06Post Ipo Equity· $150M
2022-06-14Post Ipo Equity· $172.5M
Recent News
2026-01-13
Investor's Business Daily
2026-01-13
Company data provided by crunchbase